Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cells

Amino Acids

Volumn 48, Issue 4, 2016, Pages 1003-1012

  Li, Jun ^a,b   Cameron, Gary A ^a   Wallace, Heather M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Polyamines; Prostate cancer; SSAT

Indexed keywords

ACETYLSALICYLIC ACID; ACYLTRANSFERASE; N1 ACETYLSPERMIDINE; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMIDINE SPERMINE N1 ACETYLTRANSFERASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DIAMINE N-ACETYLTRANSFERASE; SPERMINE;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME DEGRADATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN DETERMINATION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG RESISTANCE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE; TUMOR CELL LINE;

ACETYLTRANSFERASES; ANTICARCINOGENIC AGENTS; ASPIRIN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MALE; PROSTATE; PUTRESCINE; SPERMIDINE; SPERMINE;

EID: 84951774969     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-015-2143-6     Document Type: Article

References (34)

1. 1-acetyltransferase (SSAT) by aspirin in caco-2 colon cancer cells. Biochem J 394:317-324. doi: 10.1042/BJ20051298
2. Bettuzzi S, Davalli P, Astancolle S, Carani C, Madeo B, Tampieri A, Corti A. (2000) Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. Cancer Res 60:28-34 (PubMed ID: 10646846)
3. Bosetti C, Gallus S, La Vecchia C (2009) Aspirin and cancer risk: a summary review to 2007. Recent Results Cancer Res 181:231-251. doi: 10.1007/978-3-540-69297-3-22
4. Chan AT, Ogino S, Fuchs CS (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356:2131-2142. doi: 10.1056/NEJMoa067208
5. Criss WE (2003) A review of polyamines and cancer. Turkish J Med Sci 33:195-206
6. Dozmorov MG, Hurst RE. Culkin DJ, Kropp BP, Frank MB, Osban J, Penning TM, Lin HK (2009) Prostate 69:1077-1090. doi: 10.1002/pros.20960
7. Globocan 2008: Cancer incidence and mortality worldwide. International Agency for Research on Cancer, WHO. Available from: http://www.iarc.fr/en/media-centre/iarcnews/2010/globocan2008.php
8. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS (2000) The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275:11397-11403. doi: 10.1074/jbc.275.15.11397
9. Hubner RA, Muir KR, Liu JF, Logan RFA, Grainge MJ, Houlston RS, Members of the UKCAP Consortium (2008) Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention. Clin Cancer Res 14:2303-2309. doi: 10.1158/1078-0432.CCR-07-4599
10. Hughes A, Saunders FR, Wallace HM (2012) Naproxen causes cytotoxicity and induces changes in polyamine metabolism independent of cyclo-oxygenase expression. Toxicol Res 1:108-115. doi: 10.1039/C2TX20018J
11. Isaacs W, De Marzo A, Nelson WG (2002) Focus on prostate cancer. Cancer Cell 2:113-116. doi: 10.1016/S1535-6108(02)00103-4
12. Kee K, Vujcic S, Merali S, Diegelman P, Kisiel N, Powell CT, Kramer DL, Porter CW (2004) Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells. J Biol Chem 279:27050-27058. doi: 10.1074/jbc.M403323200
13. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK (2009) Oxidative stress in prostate cancer. Cancer Lett 282:125-136. doi: 10.1016/j.canlet.2008.12.011
14. Kramer DL, Diegelman P, Jell J, Vujcic S, Merali S, Porter CW (2008) Polyamine acetylation modulates polyamine metabolic flux, a prelude to broader metabolic consequences. J Biol Chem 283:4241-4251. doi: 10.1074/jbc.M706806200
15. Lin DW, Nelson PS (2003) The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma. Clin Prost Cancer 2:119-126. doi: 10.3816/CGC.2003.n.020
16. Liu XH, Tao S, Kirschenbaum A, Levine AC (1998) N398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 58:4245-4249
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
18. Mahmud S, Franco E, Aprikian A (2004) Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. Br J Cancer 90:93-99. doi: 10.1038/sj.bjc.6601416
19. Mandal S, Mandal A, Johansson HE, Orjalo AV, Park MH (2013) Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells. Proc Natl Acad Sci 110:2169-2174. doi: 10.1073/pnas.1219002110
20. Michael JT, Eric JJ, Carlo P (2012) The role of aspirin in cancer prevention. Nature reviews: Clinical Oncology 9:259-267. doi: 10.1038/nrclinonc.2011.199
21. Nelson JE, Harris RE (2000) Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study. Oncol Rep 7:169-239. doi: 10.3892/or.7.1.169
22. Pegg AE (2009) Mammalian polyamine metabolism and function. IUBMB Life 61:880-894. doi: 10.1002/iub.230
23. 1-acetyltransferase. J Biol Chem 272:18746-18751. doi: 10.1074/jbc.272.30.18746
24. Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377:31-41. doi: 10.1016/S0140-6736(10)62110-1
25. 1-acetyltransferase by intracellular polyamine pools: evidence for a functional role in polyamine homeostasis. FEBS Lett 321:179-183. doi: 10.1016/0014-5793(93)80103-2
26. Sostres C, Gargallo CJ, Lanas A (2014) Aspirin, cyclooxygenase inhibition and colorectal cancer. World J Gastroin Pharmacol Therap 5:40-49. doi: 10.4292/wjgpt.v5.i1.40
27. 3H]ornithine. Methods Mole Biol Polyam Prot 79:33-39. doi: 10.1385/0-89603-448-8:33
28. Thun MJ, Jacobs EJ, Patrono C (2012) The role of aspirin in cancer prevention. Nature Rev Clin Oncol 9:259-267. doi: 10.1038/nrclinonc.2011.199
29. 1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem 275:38319-38328. doi: 10.1074/jbc.M003270200
30. Wallace HM (2000) The physiological role of the polyamines. Eur J Clin Invest 30:1-3. doi: 10.1046/j.1365-2362.2000.00585.x
31. 1-acetyltransferase activity. Methods Mol Biol Polyam Prot 79:59-68. Edited by Morgan DM. Totowa, New Jersey: Humana Press Inc. doi: 10.1385/0-89603-448-8:59
32. Wallace HM, Hughes A (2006) Protective effect of polyamines on NSAID-induced injury and apoptosis. Polyamine Cell Signaling. Physiology, Pharmacology, and Cancer Research. Edited by Wang JY, Casero Jr RA. Totowa, New Jersey: Human press Inc
33. Wallace HM, Mackarel J (1998) Regulation of polyamine acetylation and efflux in human cancer cells. Biochem Soc Trans 26:571-575. doi: 10.1042/bst0260571
34. Wallace HM, Fraser AV, Hughes A (2003) A perspective of polyamine metabolism. Biochem J 376:1-14. doi: 10.1042/BJ20031327